Weisman Harlan F 4
4 · TFF Pharmaceuticals, Inc. · Filed Dec 6, 2022
Insider Transaction Report
Form 4
Weisman Harlan F
Director
Transactions
- Award
Stock Options (Right to Buy)
2022-12-03+1,792,450→ 1,792,450 totalExercise: $1.19Exp: 2032-12-03→ Common Stock (1,792,450 underlying)
Footnotes (1)
- [F1]The Options shall vest during the period of Dr. Weisman's service as CEO of the Company as follows: Options to purchase 298,750 shares of Common Stock ("Six Month Options") shall vest upon the six-month anniversary of the date of grant and Options to purchase 49,790 shares of Common Stock shall vest in 30 monthly installments commencing on the seven-month anniversary of the date of grant. In the event of the Company's termination of Dr. Weisman's service as CEO ("Termination of Service") as a result of hiring a permanent CEO all unvested Options shall immediately expire.